subject: CHEBI:132774

subject_name: Roxadustat

object_name: sarcopenia


subject: UMLS:C3713379

tested_intervention: unsure


subject: CHEBI:9356

subject_name: Sultopride

object_name: schizophreniform disorder


subject: CHEBI:9356

object_name: schizoaffective disorder


subject: CHEBI:9356

object_name: schizophrenia 18


subject: CHEBI:64045

subject_name: Amisulpride


subject: CHEBI:64045


subject: CHEBI:64045


subject: UNII:4SY8H89134

subject_name: zircon

object_name: chronic kidney disease

tested_intervention: yes


subject: UNII:4SY8H89134

object_name: Chronic Kidney Disease, CTCAE


subject: UNII:4SY8H89134

object_name: Abnormal renal physiology


subject: CHEBI:36791

subject_name: Escitalopram

object_name: Internet Addiction Disorder


subject: CHEBI:3723

subject_name: Citalopram


subject: UMLS:C4329312

subject_name: Anti-CD133-PE38-KDEL Fusion Protein

object_name: Solid Neoplasm


subject: CHEBI:135005

subject_name: Milnacipran

object_name: Depressed mood


subject: CHEBI:135005

object_name: Cancer patients and suicide and depression


subject: CHEBI:135005

object_name: Depressed - symptom


subject: CHEBI:135005

object_name: Depression, CTCAE


subject: CHEBI:135005

object_name: Ischemic stroke


subject: PUBCHEM.COMPOUND:11332179

subject_name: pasireotide

object_name: hormone-resistant prostate carcinoma


subject: PUBCHEM.COMPOUND:11332179

object_name: Prostate cancer recurrent


subject: PUBCHEM.COMPOUND:11332179

object_name: Stage IV Prostate Cancer AJCC v6


subject: PUBCHEM.COMPOUND:11332179

object_name: Carcinoma of the prostate stage IV


subject: PUBCHEM.COMPOUND:11332179

object_name: Stage IV Prostate Cancer AJCC v7


subject: PUBCHEM.COMPOUND:11332179

object_name: Stage IV Prostate Cancer AJCC v8


subject: PUBCHEM.COMPOUND:11332179

object_name: prostate adenocarcinoma


subject: CHEBI:75045

subject_name: Dabrafenib

object_name: Stage IIIB Cutaneous Melanoma AJCC v7


subject: CHEBI:75045

object_name: Stage IIIC Cutaneous Melanoma AJCC v7


subject: CHEBI:75998

subject_name: Trametinib


subject: CHEBI:75998


subject: CHEBI:135686

subject_name: Alvimopan

object_name: ovarian cancer


subject: CHEBI:135686

object_name: ovarian neoplasm


subject: CHEBI:135686

object_name: ovarian carcinoma


subject: CHEBI:135686

object_name: peritoneum cancer


subject: CHEBI:135686

object_name: fallopian tube carcinoma


subject: CHEBI:135686

object_name: fallopian tube cancer


subject: UNII:D7RD81HE4W

subject_name: thymoglobulin

object_name: renal transplant infection


subject: UMLS:C0359156

subject_name: Thymoglobulin


subject: UNII:FU77B4U5Z0

subject_name: Ustekinumab

object_name: hematopoietic and lymphoid system neoplasm


subject: UNII:FU77B4U5Z0

object_name: hematologic disorder


subject: CHEMBL.COMPOUND:CHEMBL2107910

subject_name: OLIVE OIL

object_name: trigeminal neuralgia


subject: CHEBI:32060

subject_name: propagermanium

object_name: focal segmental glomerulosclerosis


subject: UNII:1Q2P9TO9Q7

subject_name: Propagermanium


subject: CHEBI:63637

subject_name: Vemurafenib

object_name: metastatic colorectal cancer


subject: CHEBI:31355

subject_name: Carboplatin

object_name: carcinoma of urethra


subject: CHEBI:31355

object_name: urethra cancer


subject: CHEBI:31355

object_name: urethra neoplasm


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:63791

subject_name: Lenalidomide


subject: CHEBI:63791


subject: CHEBI:63791


subject: UMLS:C0770263

subject_name: Dextrose 40% and Water

object_name: Gastrointestinal hemorrhage


subject: CHEBI:90942

subject_name: Ixazomib

object_name: glioblastoma


subject: CHEBI:90942

object_name: Childhood Glioblastoma


subject: CHEBI:90942

object_name: adult glioblastoma


subject: PUBCHEM.COMPOUND:13633150

subject_name: Methyl prednisolonate

object_name: ventilator-associated pneumonia


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: UMLS:C3853898

object_name: Carcinoma breast stage IV


subject: UNII:3A58010674

subject_name: Pegfilgrastim


subject: CHEBI:8389

subject_name: conjugated estrogens

object_name: Menopausal and female climacteric states


subject: CHEBI:17474

subject_name: Estrone sulfate


subject: PUBCHEM.COMPOUND:45357473

subject_name: Estratab


subject: CHEBI:27504

subject_name: Mitomycin

object_name: pancreatic neoplasm


subject: CHEBI:27504

object_name: exocrine pancreatic carcinoma


subject: CHEBI:27504

object_name: malignant pancreatic neoplasm


subject: CHEBI:67194

subject_name: Nabiximols


subject: CHEBI:67194


subject: CHEBI:67194


subject: CHEBI:67194

object_name: Recurrent Brain Neoplasm


subject: CHEBI:67194

object_name: brain neoplasm


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: hyperglycemia


subject: CHEBI:8228

object_name: Hyperglycemia, CTCAE


subject: CHEBI:8228

object_name: Glucose in blood specimen above reference range


subject: CHEBI:8228

object_name: Acute Stroke


subject: UMLS:C0392938

subject_name: zoledronate

object_name: breast neoplasm


subject: PUBCHEM.COMPOUND:6918224

subject_name: QUETIAPINE FUMARATE

object_name: bipolar depression


subject: PUBCHEM.COMPOUND:6918224

object_name: Depressed mood


subject: PUBCHEM.COMPOUND:6918224

object_name: Cancer patients and suicide and depression


subject: PUBCHEM.COMPOUND:6918224

object_name: Depressed - symptom


subject: PUBCHEM.COMPOUND:6918224

object_name: Depression, CTCAE


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: bipolar disorder


subject: UMLS:C0013227


subject: UMLS:C0013227


subject: UMLS:C0013227


subject: UMLS:C0013227


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: UMLS:C2917435

subject_name: Mood Stabilizer


subject: UMLS:C2917435


subject: UMLS:C2917435


subject: UMLS:C2917435


subject: UMLS:C2917435


subject: UMLS:C2917435


subject: CHEBI:75431

subject_name: ghrelin

object_name: cancer


subject: CHEBI:75431

object_name: neoplasm


subject: DRUGBANK:DB11895

subject_name: Lenomorelin


subject: DRUGBANK:DB11895


subject: UMLS:C0911014


subject: UMLS:C0911014


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Subcapital fracture of neck of femur


subject: CHEBI:50692

subject_name: Mifepristone


subject: CHEBI:50692


subject: CHEBI:50692


subject: CHEBI:50692


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara

object_name: Childhood Neuroblastoma


subject: PUBCHEM.COMPOUND:3368

object_name: neuroblastoma


subject: UMLS:C0700805


subject: UMLS:C0700805


subject: CHEBI:49165

object_name: bronchiolitis obliterans syndrome


subject: CHEBI:49165

object_name: chronic graft versus host disease


subject: CHEBI:55352

subject_name: (R)-Atenolol

object_name: atrial fibrillation


subject: CHEBI:55352

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:55352

object_name: Atrial Fibrillation, CTCAE


subject: CHEBI:2904

subject_name: Atenolol


subject: CHEBI:2904


subject: CHEBI:2904


subject: CHEBI:3127

subject_name: Bisoprolol


subject: CHEBI:3127


subject: CHEBI:3127


subject: CHEBI:64019

subject_name: Nebivolol


subject: CHEBI:64019


subject: CHEBI:64019


subject: CHEBI:8499

subject_name: Propranolol


subject: CHEBI:8499


subject: CHEBI:8499


subject: CHEBI:169833

subject_name: Deacetyldiltiazem


subject: CHEBI:169833


subject: CHEBI:169833


subject: CHEBI:82814

subject_name: Dilacor XR


subject: CHEBI:82814


subject: CHEBI:82814


subject: CHEBI:101278

subject_name: Diltiazem


subject: CHEBI:101278


subject: CHEBI:101278


subject: CHEBI:77733

subject_name: Verapamil


subject: CHEBI:77733


subject: CHEBI:77733


subject: PUBCHEM.COMPOUND:3062

subject_name: Cogoxin


subject: PUBCHEM.COMPOUND:3062


subject: PUBCHEM.COMPOUND:3062


subject: CHEBI:145795


subject: CHEBI:145795


subject: CHEBI:145795


subject: CHEBI:2038

subject_name: Azacitidine

object_name: T-Cell Lymphoma


subject: UNII:28X28X9OKV

subject_name: Durvalumab


subject: UMLS:C3641122


subject: CHEBI:71223

subject_name: Pralatrexate


subject: CHEBI:60648

subject_name: DOXYCYCLINE


subject: CHEBI:60648

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: CHEBI:60648

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:60648

object_name: follicular lymphoma


subject: CHEBI:60648

object_name: lymphoplasmacytic lymphoma


subject: CHEBI:60648

object_name: marginal zone lymphoma


subject: CHEBI:60648

object_name: MALT lymphoma


subject: CHEBI:60648

object_name: Mantle cell lymphoma recurrent


subject: CHEBI:60648

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: CHEBI:60648

object_name: Waldenstrom macroglobulinemia


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: UNII:VI6E2D3CYP

object_name: prostate cancer


subject: UNII:VI6E2D3CYP

object_name: prostate neoplasm


subject: UMLS:C5206611

subject_name: Glucocorticoid Receptor Antagonist ORIC-101


subject: UMLS:C5206611


subject: CHEMBL.COMPOUND:CHEMBL4802177


subject: CHEMBL.COMPOUND:CHEMBL4802177


subject: CHEBI:33353

subject_name: technetium atom

object_name: melanoma


subject: UMLS:C4541754

subject_name: Refresh Optive Mega-3

object_name: dry eye syndrome


subject: UMLS:C4541754

object_name: Dry Eye, CTCAE


subject: UMLS:C4541754

object_name: Dryness of eye


subject: PUBCHEM.COMPOUND:3367

object_name: plasma cell leukemia


subject: PUBCHEM.COMPOUND:3367

object_name: Plasma cell tumor, malignant


subject: PUBCHEM.COMPOUND:3367

object_name: plasma cell neoplasm


subject: PUBCHEM.COMPOUND:3367

object_name: essential thrombocythemia


subject: PUBCHEM.COMPOUND:3367

object_name: prolymphocytic leukemia


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: UMLS:C1172157

object_name: inflammatory bowel disease 1


subject: CHEBI:197638

subject_name: Carzinophilin


subject: CHEBI:197638

object_name: Crohn disease


subject: CHEBI:59495

subject_name: CIDOFOVIR

object_name: cystitis


subject: CHEBI:59495

object_name: Cystitis, CTCAE


subject: CHEBI:59495

object_name: bladder disease


subject: CHEBI:530615


subject: CHEBI:530615


subject: CHEBI:530615


subject: CHEBI:134514


subject: CHEBI:134514


subject: CHEBI:134514


subject: CHEBI:3696

subject_name: Cidofovir


subject: CHEBI:3696


subject: CHEBI:3696


subject: UNII:X85G7936GV

subject_name: Abciximab

object_name: myocardial ischemia


subject: UNII:X85G7936GV

object_name: Family history of ischemic heart disease


subject: UNII:X85G7936GV

object_name: arteriosclerosis disorder


subject: UNII:X85G7936GV

object_name: atherosclerosis


subject: CHEBI:78770

subject_name: ethylene glycol monododecyl ether

object_name: Myxoid cyst


subject: PUBCHEM.COMPOUND:2724258

subject_name: Polyethylene glycol monododecyl ether


subject: PUBCHEM.COMPOUND:76459

subject_name: Heptaethylene glycol monododecyl ether


subject: CHEBI:46859

subject_name: Polidocanol


subject: CHEBI:36791

subject_name: Escitalopram

object_name: BH4-deficient hyperphenylalaninemia A


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:7986

subject_name: Pentoxifylline

object_name: alopecia areata


subject: CHEBI:7986

object_name: alopecia


subject: DRUGBANK:DB08937

object_name: exocrine pancreatic carcinoma


subject: DRUGBANK:DB08937

object_name: malignant pancreatic neoplasm


subject: CHEBI:90876

subject_name: Lonsurf


subject: CHEBI:90876


subject: UMLS:C1508865

subject_name: Injection, omalizumab, 5 mg administered

object_name: Food allergy in children


subject: UNII:2P471X1Z11

subject_name: Omalizumab


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: endogenous depression


subject: PUBCHEM.COMPOUND:73151030

object_name: major depressive disorder


subject: CHEBI:139072

object_name: Stress Disorders, Traumatic


subject: CHEBI:139072

object_name: psychosis


subject: CHEBI:139072

object_name: mental disorder


subject: CHEBI:139072

object_name: psychiatric disorder


subject: CHEBI:139072

object_name: acute stress disorder


subject: CHEBI:8614

subject_name: Psilocybin


subject: CHEBI:8614


subject: CHEBI:8614


subject: CHEBI:8614


subject: CHEBI:8614


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: nasopharyngeal neoplasm


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: thyroid tumor


subject: UNII:GKF8S4C432

object_name: thyroid gland carcinoma


subject: UNII:GKF8S4C432

object_name: thyroid cancer


subject: GTOPDB:13790

subject_name: benmelstobart


subject: GTOPDB:13790


subject: GTOPDB:13790


subject: UNII:B25CF42QKP

subject_name: BENMELSTOBART


subject: UNII:B25CF42QKP


subject: UNII:B25CF42QKP


subject: UMLS:C5777125


subject: UMLS:C5777125


subject: UMLS:C5777125


subject: UMLS:C4744993


subject: UMLS:C4744993


subject: UMLS:C4744993


subject: CHEBI:167574

subject_name: Semaglutide

object_name: Liver Fibrosis


subject: CHEBI:167574

object_name: Type 2 diabetes mellitus in obese


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: pleural empyema


subject: CHEBI:41879

object_name: empyema


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: schizoaffective disorder


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: schizophrenia 18


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: schizophrenia


subject: CHEBI:52993

subject_name: Lormetazepam

object_name: cognitive disorder


subject: CHEBI:52993

object_name: Cognitive impairment


subject: CHEBI:6539

subject_name: Lorazepam


subject: CHEBI:6539


subject: CHEBI:63631

subject_name: Topiramate


subject: CHEBI:63631


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: brain injury


subject: CHEBI:100241

object_name: bacterial infectious disease


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE


subject: CHEBI:6909

subject_name: Metronidazole


subject: CHEBI:204928

subject_name: Cefotaxime


subject: CHEBI:204928


subject: CHEBI:42355

subject_name: Erythromycin

object_name: epidermolysis bullosa


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab

object_name: Platinum-Sensitive Fallopian Tube Carcinoma


subject: UNII:QEN1X95CIX

object_name: Platinum-Sensitive Ovarian Carcinoma


subject: UNII:QEN1X95CIX

object_name: Platinum-Sensitive Primary Peritoneal Carcinoma


subject: UNII:QEN1X95CIX

object_name: fallopian tube endometrioid tumor


subject: UNII:QEN1X95CIX

object_name: Recurrent Ovarian Serous Adenocarcinoma


subject: UNII:QEN1X95CIX

object_name: Recurrent Fallopian Tube Endometrioid Adenocarcinoma


subject: UNII:QEN1X95CIX

object_name: Recurrent Ovarian Endometrioid Adenocarcinoma


subject: UNII:QEN1X95CIX

object_name: ovarian endometrial cancer


subject: UNII:QEN1X95CIX

object_name: Fallopian Tube High Grade Serous Adenocarcinoma


subject: UNII:QEN1X95CIX

object_name: Recurrent Primary Peritoneal Endometrioid Adenocarcinoma


subject: UNII:QEN1X95CIX

object_name: Primary Peritoneal High Grade Serous Adenocarcinoma


subject: UNII:QEN1X95CIX

object_name: high grade ovarian serous adenocarcinoma


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: GTOPDB:4942

subject_name: GM-CSF

object_name: Recurrent Medulloblastoma


subject: GTOPDB:4942

object_name: Recurrent Childhood Brain Neoplasm


subject: GTOPDB:4942

object_name: Childhood Brain Neoplasm


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: UMLS:C0376563

subject_name: Recombinant Granulocyte-Macrophage Colony-Stimulating Factors


subject: UMLS:C0376563


subject: UMLS:C0376563


subject: CHEBI:74854

subject_name: Thr-Asp


subject: CHEBI:74854


subject: CHEBI:74854


subject: UMLS:C3526553

subject_name: diphtheria, tetanus toxoids and acellular pertussis vaccine


subject: UMLS:C3526553


subject: UMLS:C3526553


subject: UMLS:C0305060

subject_name: Tetanus and diphtheria toxoid adsorbed for adult use


subject: UMLS:C0305060


subject: UMLS:C0305060


subject: CHEMBL.COMPOUND:CHEMBL2108875

subject_name: TETANUS TOXOID

object_name: malignant glioma


subject: CHEMBL.COMPOUND:CHEMBL2108875


subject: CHEMBL.COMPOUND:CHEMBL2108875

object_name: glioblastoma


subject: CHEMBL.COMPOUND:CHEMBL2108875

object_name: Childhood Glioblastoma


subject: CHEMBL.COMPOUND:CHEMBL2108875

object_name: adult glioblastoma


subject: CHEMBL.COMPOUND:CHEMBL2108875


subject: CHEMBL.COMPOUND:CHEMBL2108875


subject: UMLS:C0305062

subject_name: Tetanus Toxoid


subject: UMLS:C0305062


subject: UMLS:C0305062


subject: UMLS:C0305062


subject: UMLS:C0305062


subject: UMLS:C0305062


subject: UMLS:C0305062


subject: UMLS:C0039620

subject_name: Tetanus Vaccine


subject: UMLS:C0039620


subject: UMLS:C0039620


subject: UMLS:C0039620


subject: UMLS:C0039620


subject: UMLS:C0039620


subject: UMLS:C0039620


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: Cirrhosis


subject: PUBCHEM.COMPOUND:73151030

object_name: liver cirrhosis


subject: PUBCHEM.COMPOUND:73151030

object_name: Ascites


subject: PUBCHEM.COMPOUND:73151030

object_name: Ascites, CTCAE


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: PUBCHEM.COMPOUND:4739

subject_name: Vidarbine

object_name: Myelodysplasia


subject: PUBCHEM.COMPOUND:4739


subject: CHEBI:229687


subject: CHEBI:229687


subject: CHEBI:27834

subject_name: Pentostatin


subject: CHEBI:27834


subject: UMLS:C2825026

subject_name: Unfractionated Heparin [EPC]

object_name: septic shock


subject: CHEBI:151315

subject_name: Heparin


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: CNS disorder


subject: CHEBI:231601

subject_name: trastuzumab


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: UNII:234248D0HH

subject_name: Tucatinib


subject: PUBCHEM.COMPOUND:11525088

subject_name: Elesclomol sodium

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:11525088

object_name: prostate cancer


subject: UNII:L219C7807V

subject_name: ELESCLOMOL SODIUM


subject: UNII:L219C7807V


subject: UMLS:C2699865

subject_name: Elesclomol Sodium


subject: UMLS:C2699865


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: Drug Interactions


subject: CHEBI:8382

subject_name: Prednisone


subject: UMLS:C4045833

subject_name: Decernotinib


subject: PUBCHEM.COMPOUND:52943456

subject_name: FONDAPARINUX

object_name: pulmonary embolism


subject: CHEBI:61033

subject_name: Fondaparinux


subject: CHEBI:10033

subject_name: Warfarin


subject: UNII:9RV78Q2002

subject_name: Vedolizumab

object_name: pouchitis


subject: UMLS:C1098513


subject: MESH:C511292

subject_name: Ortho Evra

object_name: Uses contraception (finding)


subject: UMLS:C1337075

subject_name: Ortho-Cyclen


subject: CHEBI:9649

subject_name: Trandolapril

object_name: type 2 diabetes mellitus


subject: CHEBI:9649

object_name: Diabetes


subject: CHEBI:9649

object_name: diabetes mellitus


subject: CHEBI:77733

subject_name: Verapamil


subject: CHEBI:77733


subject: UMLS:C2348288

subject_name: Dietary Zinc

object_name: mortality


subject: UMLS:C2348288

object_name: Morbidity


subject: CHEBI:29105

subject_name: Velmanase alfa


subject: CHEBI:29105


subject: CHEBI:27363

subject_name: Zinc


subject: CHEBI:27363


subject: UMLS:C3541396

subject_name: Zinc Supplements


subject: UMLS:C3541396


subject: UMLS:C3714650

subject_name: Zinc Drug Class


subject: UMLS:C3714650


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: estrogen-receptor positive breast cancer


subject: CHEBI:230905

subject_name: Ribociclib


subject: PUBCHEM.COMPOUND:71509114

object_name: hepatitis C


subject: UNII:9C9W4VZ22S


subject: CHEBI:50838

subject_name: Drospirenone

object_name: Osteopenia


subject: PR:000012938

subject_name: pinin


subject: CHEBI:31859

subject_name: Modafinil

object_name: outcomes general quality of life


subject: CHEBI:31859

object_name: Perceived quality of life


subject: CHEBI:31859

object_name: Good quality of life


subject: CHEMBL.COMPOUND:CHEMBL1650818

subject_name: pivmecillinam

object_name: bacteriemia


subject: CHEMBL.COMPOUND:CHEMBL1650818

object_name: Bacteremia, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL1650818

object_name: Antibiotic resistant infection


subject: CHEMBL.COMPOUND:CHEMBL1650818

object_name: urinary tract infection


subject: CHEMBL.COMPOUND:CHEMBL1650818

object_name: Recurrent urinary tract infections


subject: CHEBI:51254

subject_name: AMOXICILLIN


subject: CHEBI:51254


subject: CHEBI:51254


subject: CHEBI:51254


subject: CHEBI:51254


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:2676


subject: CHEBI:2676


subject: CHEBI:2676


subject: CHEBI:2676


subject: CHEBI:48947

subject_name: Clavulanic acid


subject: CHEBI:48947


subject: CHEBI:48947


subject: CHEBI:48947


subject: CHEBI:48947


subject: CHEBI:135530

subject_name: Solifenacin

object_name: Urinary Bladder, Underactive


subject: UMLS:C5417938

subject_name: ERK1/2 Inhibitor HH2710

object_name: Erdheim-Chester disease


subject: UMLS:C5417938

object_name: melanoma


subject: UMLS:C4725934

subject_name: Encochleated Amphotericin B

object_name: acute lymphoblastic leukemia


subject: UMLS:C4725934

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C4725934

object_name: acute myeloid leukemia


subject: PR:000049739

subject_name: calmodulin (rat)


subject: PR:000049739


subject: PR:000049739


subject: PR:000049738

subject_name: calmodulin (mouse)


subject: PR:000049738


subject: PR:000049738


subject: UniProtKB:P0DP24

subject_name: CALM2_HUMAN Calmodulin-2 (sprot)


subject: UniProtKB:P0DP24


subject: UniProtKB:P0DP24


subject: CHEMBL.COMPOUND:CHEMBL4297570

object_name: colorectal cancer


subject: CHEMBL.COMPOUND:CHEMBL4297570

object_name: colorectal carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297570

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEMBL.COMPOUND:CHEMBL4297570

object_name: colorectal neoplasm


subject: UMLS:C3273207


subject: UMLS:C3273207


subject: UMLS:C3273207


subject: UMLS:C3273207


subject: UNII:V038D626IF

subject_name: Ashwagandha

object_name: Sleep abnormality


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: cleft palate


subject: CHEBI:4466

object_name: isolated cleft palate


subject: CHEBI:4466

object_name: cleft palate on exam


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: CHEBI:7862

subject_name: Oxymetazoline

object_name: chronic rhinitis


subject: CHEBI:9667

subject_name: Triamcinolone

object_name: Nasal congestion


subject: CHEBI:9667


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: B-cell adult acute lymphocytic leukemia


subject: CHEBI:91397

object_name: Philadelphia Chromosome Positive


subject: UMLS:C4287651

subject_name: Quadrivalent Inactivated Influenza Vaccine

object_name: Immunization reaction


subject: UMLS:C4510275

subject_name: Sulfur hexafluoride lipid microsphere

object_name: Neonatal necrotizing enterocolitis


subject: UMLS:C4510275

object_name: bowel ischemic


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Metastatic Adult Malignant Neoplasm in the Brain


subject: UMLS:C2346820


subject: UMLS:C2984206

subject_name: Flanvotumab

object_name: melanoma


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: toxic or nutritional optic neuropathy


subject: UNII:2S9ZZM9Q9V

object_name: optic nerve disorder


subject: MESH:D005232

subject_name: Fatty Acids, Volatile

object_name: rheumatoid arthritis


subject: CHEBI:26666

subject_name: short-chain fatty acid


subject: CHEBI:50733

subject_name: nutraceutical


subject: CHEBI:63577

subject_name: Lamivudine

object_name: hepatitis A


subject: CHEBI:63577

object_name: hepatitis


subject: CHEBI:134512


subject: CHEBI:134512


subject: CHEBI:2469

subject_name: Adefovir


subject: CHEBI:2469


subject: CHEBI:7459

subject_name: Naloxone

object_name: opioid use


subject: UMLS:C1161331

subject_name: Saccharum officinale, sucrose, cane sugar, Homeopathic preparation

object_name: Hunger


subject: CHEBI:17992

subject_name: Sucrose


subject: UNII:3750D0U8B5

subject_name: Pexmetinib

object_name: Myelodysplasia


subject: UMLS:C2830143


subject: PR:000005882

subject_name: adapter molecule crk


subject: PR:000008220

subject_name: GRB2-related adapter protein 2


subject: PR:000014113

subject_name: E3 ubiquitin-protein ligase RNF19A


subject: PR:000003860

subject_name: activator of 90 kDa heat shock protein ATPase homolog 1


subject: PR:000012967

subject_name: polymerase delta-interacting protein 2


subject: CHEBI:150712

subject_name: Hyaluronic acid

object_name: Dry Eye, CTCAE


subject: CHEBI:150712

object_name: Dryness of eye


subject: PUBCHEM.COMPOUND:6918304

subject_name: Naproxcinod

object_name: osteoarthritis


subject: PUBCHEM.COMPOUND:6918304

object_name: osteoarthritis, hip


subject: UMLS:C0013230

subject_name: Investigational New Drugs

object_name: Seizure Related to COVID-19


subject: UMLS:C0013230

object_name: epilepsy


subject: UMLS:C0013230

object_name: visual epilepsy


subject: UMLS:C3886615


subject: UMLS:C3886615


subject: UMLS:C3886615


subject: CHEBI:73678

object_name: bronchiectasis


subject: CHEBI:28864

subject_name: Tobramycin


subject: CHEBI:15727

subject_name: Carnosine

object_name: Increased reactive oxygen species production


subject: CHEBI:15727

object_name: diabetic kidney disease


subject: CHEBI:15727

object_name: type 1 diabetes mellitus


subject: UMLS:C0007267

subject_name: carnosine


subject: UMLS:C0007267


subject: UMLS:C0007267


subject: UNII:ZU8OM8V5WF

object_name: Childhood Solid Neoplasm


subject: UNII:ZU8OM8V5WF

object_name: Adult Solid Neoplasm


subject: UNII:ZU8OM8V5WF

object_name: Solid Neoplasm


subject: UNII:ZU8OM8V5WF

object_name: triple-negative breast carcinoma


subject: UNII:ZU8OM8V5WF

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:27470

subject_name: Folic acid

object_name: cardiovascular disorder


subject: CHEBI:27470

object_name: myocardial infarction


subject: CHEBI:27470

object_name: Myocardial Infarction, CTCAE


subject: CHEBI:27470

object_name: Myocardial Infarction by ECG Finding


subject: CHEBI:27470

object_name: stroke disorder


subject: CHEBI:27470

object_name: cerebrovascular disorder


subject: CHEBI:27470

object_name: Stroke (heart beat)


subject: CHEBI:27470

object_name: Stroke, CTCAE


subject: CHEBI:27470

object_name: cancer


subject: CHEBI:27470

object_name: neoplasm


subject: CHEBI:27306

subject_name: vitamin B6


subject: CHEBI:27306


subject: CHEBI:27306


subject: CHEBI:27306


subject: CHEBI:27306


subject: CHEBI:27306


subject: CHEBI:27306


subject: CHEBI:27306


subject: CHEBI:27306


subject: CHEBI:27306


subject: CHEBI:32682

subject_name: L-argininium

object_name: impotence


subject: CHEBI:32682

object_name: Erectile Dysfunction, CTCAE


subject: CHEBI:32682

object_name: Erectile dysfunction


subject: CHEBI:29952

subject_name: L-arginine residue


subject: CHEBI:29952


subject: CHEBI:29952


subject: CHEBI:16467

subject_name: Arginine


subject: CHEBI:16467


subject: CHEBI:16467


subject: PUBCHEM.COMPOUND:3962

object_name: acute myeloid leukemia by FAB classification


subject: PUBCHEM.COMPOUND:3962

object_name: acute myeloid leukemia


subject: CHEBI:40303

subject_name: Lovastatin


subject: CHEBI:40303


subject: UMLS:C4053621

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C4053621

object_name: non-Hodgkin lymphoma


subject: CHEBI:25805

subject_name: oxygen atom

object_name: acute myocardial infarction


subject: CHEBI:25805

object_name: Acute Myocardial Infarction by ECG Finding


subject: CHEBI:15379

subject_name: Oxygen


subject: CHEBI:15379


subject: CHEBI:9130

subject_name: Sevoflurane


subject: CHEBI:9130


subject: UMLS:C0074926

subject_name: Soy Proteins

object_name: Childhood Breast Carcinoma


subject: UMLS:C0074926

object_name: breast carcinoma


subject: UMLS:C0074926

object_name: breast cancer


subject: UMLS:C3256731

subject_name: seaweed extract


subject: UMLS:C3256731


subject: UMLS:C3256731


subject: CHEBI:32139

object_name: Shock


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: acne


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: Hormone receptor positive malignant neoplasm of breast


subject: CHEBI:4953

subject_name: Exemestane


subject: CHEBI:9168

subject_name: Sirolimus

object_name: neoplastic syndrome


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: no feeling or sensation of skin


subject: UMLS:C1527137

object_name: Sensory Loss


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:16796


subject: CHEBI:52623

subject_name: iron-57 atom

object_name: anemia


subject: UMLS:C0770694

subject_name: trivalent influenza vaccine

object_name: heart failure


subject: UMLS:C0770694

object_name: Heart Failure, CTCAE


subject: UMLS:C0770694

object_name: stroke disorder


subject: UMLS:C0770694

object_name: cerebrovascular disorder


subject: UMLS:C0770694

object_name: Stroke (heart beat)


subject: UMLS:C0770694

object_name: Stroke, CTCAE


subject: MESH:D007252

subject_name: Influenza Vaccines


subject: MESH:D007252


subject: MESH:D007252


subject: MESH:D007252


subject: MESH:D007252


subject: MESH:D007252


subject: UMLS:C5395271

subject_name: Vaccine product containing only Influenza virus antigen (medicinal product)


subject: UMLS:C5395271


subject: UMLS:C5395271


subject: UMLS:C5395271


subject: UMLS:C5395271


subject: UMLS:C5395271


subject: UMLS:C3640984

subject_name: PepCan

object_name: cervical intraepithelial neoplasia


subject: UMLS:C3640984

object_name: dysplasia of cervix


subject: UNII:3A189DH42V

subject_name: Alemtuzumab

object_name: complications of organ transplant stem cells


subject: UNII:3A189DH42V

object_name: erythrocyte disorder


subject: UNII:3A189DH42V

object_name: pure red-cell aplasia


subject: CHEBI:9168


subject: CHEBI:9168


subject: UNII:2158753C7E

subject_name: Relacorilant

object_name: prostate carcinoma


subject: UNII:2158753C7E

object_name: prostate cancer


subject: UNII:2158753C7E

object_name: prostate adenocarcinoma


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: cancer


subject: CHEBI:22652

object_name: neoplasm


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class

object_name: perinatal asphyxia


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:38290

subject_name: L-ascorbate


subject: CHEBI:176783

subject_name: vitamin C


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: CHEBI:22652


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: CHEBI:4055

subject_name: Cytisine

object_name: Electronic cigarette exposure history


subject: CHEBI:29007

subject_name: Ceftriaxone

object_name: bipolar depression


subject: CHEBI:63612

subject_name: Nelarabine

object_name: Recurrent Childhood Lymphoblastic Lymphoma


subject: CHEBI:63612

object_name: Recurrent Childhood Acute Lymphoblastic Leukemia


subject: CHEBI:17650

subject_name: Hydrocortisone


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Unresectable Hepatocellular Carcinoma


subject: UMLS:C3827082


subject: CHEBI:92998

subject_name: Guanabenz

object_name: metabolic dysfunction-associated steatotic liver disease


subject: CHEBI:92998


subject: UMLS:C3827068


subject: UMLS:C3827068


subject: CHEBI:74947

subject_name: Thalidomide

object_name: skin melanoma


subject: CHEBI:499361

subject_name: Aprepitant

object_name: HIV infection


subject: CHEBI:580604

subject_name: (R)-ketamine

object_name: no feeling or sensation of skin


subject: CHEBI:580604

object_name: Sensory Loss


subject: DRUGBANK:DB19150

subject_name: Arketamine


subject: DRUGBANK:DB19150


subject: CHEBI:135704

subject_name: Sivelestat

object_name: systemic inflammatory response syndrome


subject: CHEBI:135704

object_name: aortic dissection


subject: CHEBI:135704

object_name: Aortic dissection


subject: UNII:18AP231HUP

subject_name: TEGAVIVINT

object_name: Refractory Leukemia


subject: UNII:18AP231HUP

object_name: Leukaemia recurrent


subject: DRUGBANK:DB17109

subject_name: Tegavivint


subject: DRUGBANK:DB17109


subject: CHEBI:29999

subject_name: L-serine residue

object_name: Alzheimer disease type 1


subject: CHEBI:29999

object_name: Alzheimer disease


subject: CHEBI:17115

subject_name: Serine


subject: CHEBI:17115


subject: UNII:G1G66XE93W

object_name: Plexosarcoma


subject: PUBCHEM.COMPOUND:160338

subject_name: Exosurf

object_name: fetal growth restriction


subject: PUBCHEM.COMPOUND:160338

object_name: bronchopulmonary dysplasia


subject: PUBCHEM.COMPOUND:160338

object_name: Bronchopulmonary Dysplasia, AE


subject: UMLS:C0059962


subject: UMLS:C0059962


subject: UMLS:C0059962


subject: UNII:S866O45PIG

subject_name: Beractant


subject: UNII:S866O45PIG


subject: UNII:S866O45PIG


subject: CHEBI:75922

subject_name: Nepafenac

object_name: Inflammatory abnormality of the eye


subject: UNII:D33CAJ796A

subject_name: GI HEPTAPEPTIDE

object_name: Barrett esophagus


subject: UNII:D33CAJ796A

object_name: esophageal adenocarcinoma


subject: UMLS:C3273550

subject_name: GI heptapeptide


subject: UMLS:C3273550


subject: UMLS:C1174135

object_name: endometriosis


subject: CHEBI:87631

subject_name: statin

object_name: Post-ERCP acute pancreatitis


subject: CHEBI:9150

subject_name: Simvastatin


subject: RXCUI:36572

subject_name: Sinemet

object_name: Parkinson disease


subject: DRUGBANK:DB06319


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: Recurrent Hepatocellular Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: GTOPDB:12990

subject_name: sintilimab


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: UMLS:C4329335

subject_name: IBI 308


subject: CHEBI:85994

subject_name: Lenvatinib


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: CHEBI:94490

subject_name: Danusertib

object_name: leukemia


subject: CHEBI:94490

object_name: childhood leukemia


subject: CHEBI:231614

subject_name: Nivolumab

object_name: low grade glioma


subject: UMLS:C2346820


subject: UNII:ZE15FIT23E

subject_name: ranpirnase

object_name: malignant mesothelioma


subject: UMLS:C0069919


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: subarachnoid hemorrhage


subject: CHEBI:26710

object_name: Acute Kidney Injury, CTCAE


subject: CHEBI:32138

subject_name: SODIUM ACETATE


subject: CHEBI:32138

object_name: acute kidney failure


subject: CHEBI:32138


subject: CHEBI:91899

object_name: sclerosing cholangitis


subject: CHEBI:3207

subject_name: Budesonide


subject: GTOPDB:8313

subject_name: talazoparib

object_name: squamous cell carcinoma


subject: CHEBI:66964

subject_name: Dronabinol

object_name: Nausea, CTCAE_5


subject: CHEBI:66964

object_name: Nausea


subject: CHEBI:66964

object_name: Nausea, CTCAE_3


subject: CHEBI:66964

object_name: Vomiting, CTCAE


subject: CHEBI:66964

object_name: Vomiting


subject: CHEBI:66964

object_name: brain cancer


subject: CHEBI:66964

object_name: brain neoplasm


subject: UNII:2S9ZZM9Q9V

object_name: Plexosarcoma


subject: PUBCHEM.COMPOUND:44210114

subject_name: Lurasidone

object_name: bipolar I disorder


subject: UMLS:C5700426

subject_name: furmonertinib

object_name: Advanced lung cancer


subject: UMLS:C0879250

subject_name: HER-2-neu peptide vaccine

object_name: Breast cancer recurrent


subject: UMLS:C0069515

subject_name: erbB-2 Receptor


subject: UNII:5TAA004E22

subject_name: Sargramostim

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UNII:5TAA004E22

object_name: Carcinoma breast stage IV


subject: UNII:5TAA004E22

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: male breast carcinoma


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22

object_name: HER2 positive breast carcinoma


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: UMLS:C5667054

subject_name: Anti-CD73 Monoclonal Antibody JAB-BX102

object_name: Childhood Solid Neoplasm


subject: UMLS:C5667054

object_name: Adult Solid Neoplasm


subject: UMLS:C5667054

object_name: Solid Neoplasm


subject: UMLS:C5447539

subject_name: Anti-CD73 Monoclonal Antibody


subject: UMLS:C5447539


subject: UMLS:C5447539


subject: UMLS:C4289970

subject_name: Anti-PD1 Monoclonal Antibody


subject: UMLS:C4289970


subject: UMLS:C4289970


subject: CHEBI:49325

subject_name: oral contraceptive

object_name: HIV infection


subject: UMLS:C0009905

subject_name: Contraceptives, Oral


subject: PUBCHEM.COMPOUND:60787

subject_name: Saquinavir

object_name: pulmonary hypertension, primary, 1


subject: PUBCHEM.COMPOUND:60787

object_name: pulmonary hypertension


subject: PUBCHEM.COMPOUND:60787

object_name: idiopathic pulmonary arterial hypertension


subject: PUBCHEM.COMPOUND:60787

object_name: pulmonary arterial hypertension


subject: CHEBI:45409

subject_name: Ritonavir


subject: CHEBI:45409


subject: CHEBI:45409


subject: CHEBI:45409


subject: DRUGBANK:DB15599

object_name: osteoarthritis, knee


subject: UNII:4RA0KN46E0

subject_name: Upadacitinib

object_name: inflammatory bowel disease 1


subject: UMLS:C5854449

subject_name: MEK1/2 Inhibitor ABM-168

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5854449

object_name: RAF Family Gene Mutation


subject: UMLS:C5854449

object_name: RAS Family Gene Mutation


subject: UNII:2LHZ9ZC3YO

subject_name: Tolinapant

object_name: Recurrent Ovarian Carcinosarcoma


subject: UNII:2LHZ9ZC3YO

object_name: Recurrent Ovarian Adenocarcinoma


subject: UNII:2LHZ9ZC3YO

object_name: Recurrent Ovarian Clear Cell Adenocarcinoma


subject: UNII:2LHZ9ZC3YO

object_name: Recurrent Platinum-Resistant Ovarian Carcinoma


subject: UNII:2LHZ9ZC3YO

object_name: Recurrent Ovarian Seromucinous Carcinoma


subject: UNII:2LHZ9ZC3YO

object_name: Recurrent Ovarian Undifferentiated Carcinoma


subject: UNII:2LHZ9ZC3YO

object_name: Recurrent Ovarian High Grade Serous Adenocarcinoma


subject: UNII:2LHZ9ZC3YO

object_name: Recurrent Platinum-Resistant Primary Peritoneal Carcinoma


subject: UNII:2LHZ9ZC3YO

object_name: Recurrent Primary Peritoneal Carcinosarcoma


subject: UNII:2LHZ9ZC3YO

object_name: Recurrent Primary Peritoneal Adenocarcinoma


subject: UNII:2LHZ9ZC3YO

object_name: Recurrent Platinum-Resistant Fallopian Tube Carcinoma


subject: UNII:2LHZ9ZC3YO

object_name: Platinum-Refractory Ovarian Carcinoma


subject: UNII:2LHZ9ZC3YO

object_name: Recurrent Primary Peritoneal Clear Cell Adenocarcinoma


subject: UNII:2LHZ9ZC3YO

object_name: Recurrent Primary Peritoneal Undifferentiated Carcinoma


subject: UNII:2LHZ9ZC3YO

object_name: Recurrent Fallopian Tube Adenocarcinoma


subject: UNII:2LHZ9ZC3YO

object_name: Recurrent Primary Peritoneal High Grade Serous Adenocarcinoma


subject: UNII:2LHZ9ZC3YO

object_name: Recurrent Fallopian Tube Carcinosarcoma


subject: UNII:2LHZ9ZC3YO

object_name: Recurrent Fallopian Tube Clear Cell Adenocarcinoma


subject: UNII:2LHZ9ZC3YO

object_name: Recurrent Fallopian Tube Undifferentiated Carcinoma


subject: UNII:2LHZ9ZC3YO

object_name: Recurrent High Grade Endometrioid Adenocarcinoma


subject: UNII:2LHZ9ZC3YO

object_name: Recurrent Fallopian Tube High Grade Serous Adenocarcinoma


subject: UNII:2LHZ9ZC3YO

object_name: Platinum-Refractory Primary Peritoneal Carcinoma


subject: UNII:2LHZ9ZC3YO

object_name: Platinum-Refractory Fallopian Tube Carcinoma


subject: CHEBI:34574

object_name: type 1 diabetes mellitus


subject: CHEBI:42085

subject_name: 7,8-Diamino-Nonanoic Acid


subject: CHEBI:16026

subject_name: 2,6-Diaminopimelic Acid


subject: CHEBI:2247

subject_name: 7,8-diaminononanoic acid


subject: CHEBI:8228

subject_name: Pioglitazone


subject: CHEBI:231683

subject_name: Anakinra

object_name: Advanced cancer


subject: CHEBI:231683

object_name: refractory malignant neoplasm


subject: CHEBI:231683

object_name: Recurrent Malignant Neoplasm


subject: CHEBI:231683

object_name: Embolism, Tumor


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: PR:000001137


subject: PR:000001137


subject: PR:000001137


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab


subject: UNII:4EQZ6YO2HI


subject: UNII:4EQZ6YO2HI


subject: UNII:4EQZ6YO2HI


subject: UMLS:C1530450

subject_name: AMG 162


subject: UMLS:C1530450


subject: UMLS:C1530450


subject: UMLS:C1530450


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204


subject: UNII:DOB7Y3RSX0

subject_name: HPPH

object_name: oropharyngeal carcinoma


subject: UNII:DOB7Y3RSX0

object_name: oral cavity carcinoma


subject: UNII:DOB7Y3RSX0

object_name: dysplasia


subject: CHEBI:166975

subject_name: soybean oil

object_name: intestinal obstruction


subject: CHEBI:166975

object_name: short bowel syndrome


subject: CHEBI:166975

object_name: Fistula of intestine, excluding rectum and anus


subject: CHEBI:166975

object_name: intestinal fistula


subject: CHEBI:166975

object_name: inflammatory bowel disease 1


subject: CHEBI:166975

object_name: Crohn disease


subject: DRUGBANK:DB09422

subject_name: Soybean oil


subject: DRUGBANK:DB09422


subject: DRUGBANK:DB09422


subject: DRUGBANK:DB09422


subject: DRUGBANK:DB09422


subject: DRUGBANK:DB09422


subject: UNII:C9H2L21V7U

subject_name: SMOFlipid


subject: UNII:C9H2L21V7U


subject: UNII:C9H2L21V7U


subject: UNII:C9H2L21V7U


subject: UNII:C9H2L21V7U


subject: UNII:C9H2L21V7U


subject: CHEBI:7514

subject_name: Neostigmine

object_name: post operative nausea and vomiting


subject: PUBCHEM.COMPOUND:74030550

subject_name: Sugammadex


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: malignant neoplasm of ovary stage IV


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Ovarian cancer stage IV


subject: UNII:28X28X9OKV


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: CHEBI:83766

subject_name: Olaparib


subject: UNII:P76B05O5V6

subject_name: Relugolix

object_name: Oligometastatic Prostate Carcinoma


subject: UNII:P76B05O5V6

object_name: Stage IVB Prostate Cancer AJCC v8


subject: UNII:P76B05O5V6

object_name: Prostate Intraductal Carcinoma


subject: UNII:P76B05O5V6

object_name: Endometrioid carcinoma of prostate


subject: CHEBI:32150

object_name: Drug-Induced Ototoxicity


subject: CHEBI:132112


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: Mannosidosis


subject: UMLS:C0003442

object_name: mucopolysaccharidosis type 6


subject: UMLS:C0003442

object_name: mucopolysaccharidosis type 1


subject: CHEBI:7915

subject_name: Pantoprazole

object_name: atrial fibrillation


subject: CHEBI:7915

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:7915

object_name: Atrial Fibrillation, CTCAE


subject: CHEBI:75929

object_name: stroke disorder


subject: CHEBI:75929

object_name: cerebrovascular disorder


subject: CHEBI:75929

object_name: Stroke (heart beat)


subject: CHEBI:75929

object_name: Stroke, CTCAE


subject: CHEBI:40009

subject_name: Cycloserine


subject: CHEBI:40009


subject: CHEBI:40009


subject: CHEBI:40009


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: small cell lung carcinoma


subject: GTOPDB:9758

object_name: lung cancer


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: UMLS:C1170584

subject_name: Restasis

object_name: Ocular surface disease


subject: UMLS:C1170584

object_name: Ocular Surface Disease, CTCAE


subject: CHEBI:4653

subject_name: Dipyridamole

object_name: Reperfusion Injury


subject: CHEBI:231350

subject_name: Pacritinib

object_name: Drug Interactions


subject: UNII:6A901E312A

subject_name: Panitumumab


subject: UMLS:C4745070

subject_name: GSK-3 Inhibitor 9-ING-41

object_name: Osteosarcoma


subject: UMLS:C4745070

object_name: bone sarcoma


subject: UMLS:C4745070

object_name: Childhood Soft Tissue Sarcoma


subject: UMLS:C4745070

object_name: Adult Soft Tissue Sarcoma


subject: UMLS:C4745070

object_name: sarcoma


subject: UMLS:C4745070

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UMLS:C4745070

object_name: soft tissue sarcoma


subject: UMLS:C4745070

object_name: adult liposarcoma


subject: UMLS:C4745070

object_name: liposarcoma


subject: UMLS:C4745070

object_name: pediatric liposarcoma


subject: UMLS:C4745070

object_name: Ewing sarcoma of bone


subject: UMLS:C4745070

object_name: pediatric angiosarcoma


subject: UMLS:C4745070

object_name: angiosarcoma


subject: UMLS:C4745070

object_name: Adult Angiosarcoma


subject: UMLS:C4745070

object_name: pediatric osteosarcoma


subject: UMLS:C4745070

object_name: High Grade Sarcoma


subject: UMLS:C4745070

object_name: Childhood Synovial Sarcoma


subject: UMLS:C4745070

object_name: Adult Synovial Sarcoma


subject: UMLS:C4745070

object_name: synovial sarcoma


subject: UMLS:C4745070

object_name: leiomyosarcoma


subject: UMLS:C4745070

object_name: Childhood Leiomyosarcoma


subject: UMLS:C4745070

object_name: Adult Leiomyosarcoma


subject: UMLS:C4745070

object_name: spindle cell sarcoma


subject: UMLS:C4745070

object_name: Adult Rhabdomyosarcoma


subject: UMLS:C4745070

object_name: rhabdomyosarcoma


subject: UMLS:C4745070

object_name: Childhood Rhabdomyosarcoma


subject: UMLS:C4745070

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: UMLS:C4745070

object_name: myxofibrosarcoma


subject: UMLS:C4745070

object_name: undifferentiated pleomorphic sarcoma


subject: UMLS:C4745070

object_name: Childhood Undifferentiated Pleomorphic Sarcoma


subject: CHEBI:4672

subject_name: Docetaxel

object_name: bone sarcoma


subject: CHEBI:4672

object_name: Ewing sarcoma of bone


subject: CHEBI:4672

object_name: High Grade Sarcoma


subject: CHEBI:4672

object_name: Childhood Synovial Sarcoma


subject: CHEBI:4672

object_name: Adult Synovial Sarcoma


subject: CHEBI:4672

object_name: synovial sarcoma


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: UMLS:C3496088

subject_name: eggplant extract

object_name: inherited lipid metabolism disorder


subject: UMLS:C3496088

object_name: Dyslipidemia


subject: CHEBI:39669

subject_name: Diflunisal

object_name: amyloidosis


subject: CHEBI:77562

subject_name: rac-crizotinib

object_name: NF2-related schwannomatosis


subject: CHEBI:77562

object_name: vestibular schwannomatosis


subject: CHEBI:64310

subject_name: Crizotinib


subject: CHEBI:64310


subject: CHEBI:60799

subject_name: Esketamine

object_name: Neuroses, Anxiety


subject: CHEBI:60799

object_name: Anxiety state


subject: UMLS:C0596581

subject_name: Fluoropyrimidine

object_name: digestive system cancer


subject: UMLS:C3859470

subject_name: Obizur

object_name: acquired hemophilia A


subject: CHEBI:29007

subject_name: Ceftriaxone

object_name: acute pyelonephritis


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: sudden sensorineural hearing loss


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: CHEBI:15940

subject_name: Niacin

object_name: hypolipoproteinemia


subject: CHEBI:17154

subject_name: Nicotinamide


subject: UNII:4B115V09LB

subject_name: Rivipansel

object_name: sickle cell disease


subject: UNII:13ZT6YG5SD

subject_name: methamphetamine

object_name: stimulant use


subject: CHEBI:6809

subject_name: Metamfetamine


subject: RXCUI:8375

subject_name: placebo Oral Tablet


subject: CHEBI:15765

subject_name: Levodopa

object_name: multiple system atrophy


subject: UMLS:C5575704

subject_name: Gene Therapy [APC]

object_name: Drug toxicity


subject: UMLS:C5575704

object_name: myelosuppression


subject: CHEBI:6520

subject_name: Lomustine


subject: CHEBI:6520


subject: CHEBI:71417

subject_name: Procarbazine


subject: CHEBI:71417


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: UNII:T5IRO3534A


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: PUBCHEM.COMPOUND:3717450


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:135005

subject_name: Milnacipran

object_name: rheumatoid arthritis


subject: PUBCHEM.COMPOUND:6433115

subject_name: reparixin

object_name: Carcinoma breast stage IV


subject: UMLS:C0013230

subject_name: Investigational New Drugs

object_name: pulmonary tuberculosis


subject: UMLS:C0013230

object_name: Hypoalbuminemia, CTCAE


subject: UMLS:C0013230

object_name: Serum albumin level decreased below normal (finding)


subject: UMLS:C0013230

object_name: Hypoalbuminemia


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: spinal cord injury


subject: CHEBI:81579

subject_name: Erythropoietin


subject: PUBCHEM.COMPOUND:12814875

subject_name: Artenimol

object_name: Androgen excess


subject: PUBCHEM.COMPOUND:456410


subject: PUBCHEM.COMPOUND:540327

subject_name: Dihydroartemisinin


subject: UMLS:C0594372

subject_name: Avonex

object_name: Pregnant


subject: UMLS:C0594372

object_name: Prenatal Exposure Delayed Effects


subject: UNII:XRO4566Q4R

subject_name: INTERFERON BETA


subject: UNII:XRO4566Q4R


subject: PUBCHEM.COMPOUND:18772499

subject_name: Inulin

object_name: Well adult


subject: UMLS:C2183198

subject_name: diagnostic drugs renal inulin


subject: UMLS:C1145756

subject_name: Lycopersicum esculentum, tomato


subject: DRUGBANK:DB10573

subject_name: Tomato


subject: UMLS:C0885519

subject_name: Tomato preparation


subject: CHEBI:73604

subject_name: Lys-Gly


subject: UMLS:C5815510

object_name: Childhood Kidney Disorder


subject: UMLS:C5815510

object_name: Diarrhea-associated hemolytic uremic syndrome


subject: UMLS:C5815510

object_name: hemolytic-uremic syndrome


subject: UNII:6897GXD6OE

object_name: Megaloblastic anemia due to vitamin B>12< deficiency


subject: PUBCHEM.COMPOUND:16056828

object_name: iron deficiency anemia


subject: PUBCHEM.COMPOUND:16056828


subject: CHEBI:27786

subject_name: Hydroxocobalamin


subject: CHEBI:27786


subject: DRUGBANK:DB10447

subject_name: Saccharomyces cerevisiae

object_name: Dyslipidemia


subject: CHEBI:15367

subject_name: Tretinoin

object_name: lung cancer


subject: CHEBI:15367

object_name: lung neoplasm


subject: CHEBI:15367

object_name: lung carcinoma


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: adult liposarcoma


subject: UNII:2S9ZZM9Q9V

object_name: liposarcoma


subject: UNII:2S9ZZM9Q9V

object_name: pediatric liposarcoma


subject: UNII:2S9ZZM9Q9V

object_name: fibrosarcoma


subject: UNII:2S9ZZM9Q9V

object_name: adult fibrosarcoma


subject: UNII:2S9ZZM9Q9V

object_name: pediatric fibrosarcoma


subject: UNII:2S9ZZM9Q9V

object_name: Childhood Synovial Sarcoma


subject: UNII:2S9ZZM9Q9V

object_name: Adult Synovial Sarcoma


subject: UNII:2S9ZZM9Q9V

object_name: synovial sarcoma


subject: UNII:2S9ZZM9Q9V

object_name: benign fibrous histiocytoma


subject: UMLS:C3714648

subject_name: Vitamin K Drug Class

object_name: Calcific Uraemic Arteriolopathy


subject: UMLS:C3714648

object_name: calciphylaxis


subject: UMLS:C3541380

subject_name: Vitamin K containing hemostatics


subject: UMLS:C3541380


subject: CHEBI:28384

subject_name: vitamin K


subject: CHEBI:28384


subject: CHEBI:18067

subject_name: Phylloquinone


subject: CHEBI:18067


subject: UMLS:C2936884

subject_name: Vitamin K [EPC]


subject: UMLS:C2936884


subject: UMLS:C0719605

subject_name: Cytogam

object_name: Disorder of transplanted kidney


subject: UMLS:C0719605

object_name: cytomegalovirus infection


subject: CHEBI:231342

subject_name: ceralasertib

object_name: Recurrent ovarian cancer


subject: CHEBI:231342

object_name: Recurrent Fallopian Tube Carcinoma


subject: CHEBI:231342

object_name: Recurrent Primary Peritoneal Carcinoma


subject: PUBCHEM.COMPOUND:44424639

subject_name: Vinorelbine

object_name: plasma cell myeloma


subject: CHEBI:93786


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: metastatic prostate carcinoma


subject: PUBCHEM.COMPOUND:5466794

subject_name: Flavopiridol

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:47344

subject_name: Alvocidib


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: Severe Sepsis


subject: CHEBI:31550

subject_name: Patupilone

object_name: Solid Neoplasm


subject: CHEBI:7772

subject_name: omeprazole


subject: CHEBI:77260

subject_name: Omeprazole


subject: UNII:072985Y799

subject_name: Perfluorooctyl iodide

object_name: bronchopulmonary dysplasia


subject: UNII:072985Y799

object_name: Bronchopulmonary Dysplasia, AE


subject: CHEBI:38803

subject_name: Perflubron


subject: CHEBI:38803


subject: DRUGBANK:DB05049

object_name: irritable bowel syndrome


subject: DRUGBANK:DB05049

object_name: irritable bowel syndrome with constipation


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous

object_name: focal epilepsy


subject: UMLS:C0085297

object_name: epilepsy


subject: UMLS:C0085297

object_name: autoimmune disorder of the nervous system


subject: UMLS:C0085297

object_name: Epilepsy, Cryptogenic


subject: UMLS:C0085297

object_name: paraneoplastic limbic encephalitis


subject: UMLS:C0085297

object_name: limbic encephalitis


subject: GTOPDB:11278

subject_name: bemarituzumab

object_name: endometrial carcinoma


subject: GTOPDB:11278

object_name: cervical cancer


subject: GTOPDB:11278

object_name: cervical carcinoma


subject: GTOPDB:11278

object_name: ovarian cancer


subject: GTOPDB:11278

object_name: ovarian neoplasm


subject: GTOPDB:11278

object_name: ovarian carcinoma


subject: UNII:RJW23BQ0KW


subject: UNII:RJW23BQ0KW


subject: UNII:RJW23BQ0KW


subject: UNII:RJW23BQ0KW


subject: UNII:RJW23BQ0KW


subject: UNII:RJW23BQ0KW


subject: UMLS:C3896858


subject: UMLS:C3896858


subject: UMLS:C3896858


subject: UMLS:C3896858


subject: UMLS:C3896858


subject: UMLS:C3896858


subject: CHEBI:180905

subject_name: Nicardipine

object_name: thoracic aortic aneurysm


subject: CHEBI:52993

subject_name: Lormetazepam

object_name: alcohol withdrawal


subject: CHEBI:6539

subject_name: Lorazepam


subject: PUBCHEM.COMPOUND:74030550

subject_name: Sugammadex

object_name: Injury to nerve during surgery


subject: PUBCHEM.COMPOUND:21628493

subject_name: ESTROGEN

object_name: Hot Flashes, CTCAE


subject: PUBCHEM.COMPOUND:21628493

object_name: Hot flashes


subject: CHEBI:50114

subject_name: estrogen


subject: CHEBI:50114


subject: UMLS:C2936882

subject_name: Estrogen [EPC]


subject: UMLS:C2936882


subject: CHEBI:75998

subject_name: Trametinib

object_name: Recurrent Rectal Cancer


subject: CHEBI:75998

object_name: Stage IIIC Rectal Cancer AJCC v7


subject: CHEBI:75998

object_name: Stage IIIC Rectal Cancer AJCC v8


subject: CHEBI:75998

object_name: Stage IIIA Rectal Cancer AJCC v7


subject: CHEBI:75998

object_name: Stage IIIA Rectal Cancer AJCC v8


subject: CHEBI:75998

object_name: stage IIIA rectal cancer


subject: CHEBI:75998

object_name: Stage IIIB Rectal Cancer AJCC v8


subject: CHEBI:75998

object_name: Stage IIIB Rectal Cancer AJCC v7


subject: CHEBI:75998

object_name: Stage IIA Rectal Cancer AJCC v7


subject: CHEBI:75998

object_name: Stage IIA Rectal Cancer AJCC v8


subject: CHEBI:75998

object_name: stage IIB rectal cancer


subject: CHEBI:75998

object_name: Stage IIB Rectal Cancer AJCC v7


subject: CHEBI:75998

object_name: Stage IIB Rectal Cancer AJCC v8


subject: CHEBI:75998

object_name: Stage IIC Rectal Cancer AJCC v7


subject: CHEBI:75998

object_name: Stage IIC Rectal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: germ cell tumor


subject: PUBCHEM.COMPOUND:1805

object_name: Secondary malignant neoplasm of lung


subject: PUBCHEM.COMPOUND:1805

object_name: melanoma


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: CHEBI:2038


subject: GTOPDB:11376

subject_name: bintrafusp alfa

object_name: malignant soft tissue neoplasm


subject: GTOPDB:11376

object_name: sarcoma


subject: GTOPDB:11376


subject: GTOPDB:11376


subject: GTOPDB:11376


subject: CHEMBL.COMPOUND:CHEMBL4298024

subject_name: BINTRAFUSP ALFA


subject: CHEMBL.COMPOUND:CHEMBL4298024


subject: CHEMBL.COMPOUND:CHEMBL4298024


subject: CHEMBL.COMPOUND:CHEMBL4298024


subject: CHEMBL.COMPOUND:CHEMBL4298024


subject: UMLS:C4086994


subject: UMLS:C4086994


subject: UMLS:C4086994


subject: UMLS:C4086994


subject: UMLS:C4086994


subject: UMLS:C5565453

object_name: malaria


subject: UMLS:C2703124

object_name: prostate carcinoma


subject: UMLS:C2703124

object_name: prostate cancer


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: monoclonal B-cell lymphocytosis


subject: CHEBI:18361

object_name: Non-Erosive Reflux Disease


subject: CHEBI:18361

object_name: Barrett esophagus


subject: CHEBI:53266

subject_name: poly(propylene imine) macromolecule


subject: CHEBI:53266


subject: CHEBI:35782

subject_name: diphosphate ion


subject: CHEBI:35782


subject: CHEBI:60614

subject_name: poly(propylene imine) polymer


subject: CHEBI:60614


subject: CHEBI:29888

subject_name: Pyrophosphate


subject: CHEBI:29888


subject: UMLS:C0358591

subject_name: Proton Pump Inhibitors


subject: UMLS:C0358591


subject: CHEBI:91758

object_name: migraine


subject: CHEBI:91758

object_name: migraine with or without aura, susceptibility to, 1


subject: CHEBI:4562

subject_name: Dihydroergotamine


subject: CHEBI:4562


subject: UMLS:C3272757

subject_name: Live attenuated Influenza virus antigen only vaccine product

object_name: childhood onset asthma


subject: UMLS:C3272757

object_name: Immunization reaction


subject: UMLS:C3272757

object_name: Vaccine adverse reaction


subject: UMLS:C3272757

object_name: Wheezing


subject: UMLS:C3272757

object_name: Wheezing, CTCAE


subject: PUBCHEM.COMPOUND:155543961

subject_name: LIRAGLUTIDE

object_name: chronic kidney disease


subject: PUBCHEM.COMPOUND:155543961

object_name: Chronic uremia


subject: UMLS:C1099192


subject: UMLS:C1099192


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: digestive system neuroendocrine tumor, grade 1/2


subject: CHEBI:233362

object_name: digestive system neuroendocrine neoplasm


subject: CHEBI:233362

object_name: pancreatic neuroendocrine tumor


subject: CHEBI:233362

object_name: Neuroendocrine tumor of pancreas


subject: CHEBI:233362

object_name: Refractory Digestive System Neuroendocrine Neoplasm


subject: CHEBI:233362

object_name: Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm


subject: CHEBI:233362

object_name: Advanced Digestive System Neuroendocrine Neoplasm


subject: CHEBI:233362

object_name: Midgut Neuroendocrine Tumor


subject: CHEBI:233362

object_name: Hindgut Neuroendocrine Tumor


subject: CHEBI:233362

object_name: Foregut Neuroendocrine Tumor


subject: CHEBI:233362

object_name: Metastatic Digestive System Neuroendocrine Neoplasm


subject: CHEBI:9130

subject_name: Sevoflurane

object_name: acute respiratory distress syndrome


subject: CHEBI:9130

object_name: adult acute respiratory distress syndrome


subject: UMLS:C3253111

object_name: non-small cell squamous lung carcinoma


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: psoriatic arthritis


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C3489751

object_name: inherited lipid metabolism disorder


subject: UMLS:C3489751

object_name: Dyslipidemia


subject: CHEBI:6121

subject_name: Ketamine

object_name: sickle cell disease


subject: UNII:GO90DFK14U

subject_name: inolimomab

object_name: Steroid Refractory Graft Versus Host Disease


subject: UMLS:C0905677


subject: UMLS:C5227807

subject_name: Leukotac


subject: CHEBI:71954

subject_name: Buparlisib

object_name: head and neck squamous cell carcinoma


subject: UNII:TUK9QB44B0

object_name: arthritis


subject: UNII:TUK9QB44B0

object_name: Arthritis, CTCAE


subject: UMLS:C5392518


subject: UMLS:C5392518


subject: UNII:CUJ2MVI71Y

subject_name: Daclizumab

object_name: HIV infection


subject: UMLS:C0281549

subject_name: Zenapax


subject: PUBCHEM.COMPOUND:18772499

subject_name: Inulin

object_name: Prediabetes


subject: UMLS:C2183198

subject_name: diagnostic drugs renal inulin


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Human Papilloma Virus, Female


subject: UNII:28X28X9OKV

object_name: Human Papilloma Virus, Male


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: MESH:C000657484


subject: MESH:C000657484


subject: MESH:C000657484

object_name: Neck Carcinoma


subject: MESH:C000657484

object_name: head and neck neoplasm


subject: MESH:C000657484

object_name: head and neck cancer


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: Intracranial glioma


subject: CHEBI:72564

subject_name: Temozolomide


subject: PUBCHEM.COMPOUND:155369486

subject_name: MUVALAPLIN

object_name: elevated lipoprotein (a)


subject: UNII:HSU2KY4EFK


subject: UNII:X85G7936GV

subject_name: Abciximab

object_name: stricture


subject: UNII:X85G7936GV

object_name: stroke disorder


subject: UNII:X85G7936GV

object_name: cerebrovascular disorder


subject: UNII:X85G7936GV

object_name: Stroke (heart beat)


subject: UNII:X85G7936GV

object_name: Stroke, CTCAE


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: urinary tract infection


subject: CHEBI:41879

object_name: bacterial urinary tract infection


subject: CHEBI:41879

object_name: Urinary Tract Infection, CTCAE


subject: CHEBI:41879

object_name: Acute urinary tract infection


subject: CHEBI:166520

subject_name: Tenamfetamine

object_name: borderline personality disorder


subject: CHEBI:1391

subject_name: Midomafetamine


subject: UNII:N9B0H171MJ

subject_name: Derazantinib

object_name: gastric adenocarcinoma


subject: PUBCHEM.COMPOUND:23724878

subject_name: dalbavancin

object_name: prosthesis-related infectious disease


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: membranous glomerulonephritis


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:134709

subject_name: Pitolisant

object_name: Alcohol-Induced Disorders, Nervous System


subject: UMLS:C1873351


subject: UNII:Q1IF8M2YL3

subject_name: Ozarelix

object_name: lower urinary tract symptom


subject: UNII:Q1IF8M2YL3

object_name: benign prostatic hyperplasia


subject: CHEMBL.COMPOUND:CHEMBL2108312

subject_name: OZARELIX


subject: CHEMBL.COMPOUND:CHEMBL2108312


subject: UMLS:C2987000

subject_name: ozarelix


subject: UMLS:C2987000


subject: CHEBI:33325

subject_name: radium atom

object_name: metastatic prostate carcinoma


subject: CHEBI:33325

object_name: Stage IVB Prostate Cancer AJCC v8


subject: UNII:90ZX3Q3FR7

subject_name: Risankizumab

object_name: asthma


subject: UMLS:C4078397


subject: CHEBI:8364

subject_name: Prazosin

object_name: nicotine dependence


subject: CHEBI:27374

subject_name: Levoinositol

object_name: endometriosis


subject: CHEBI:27372


subject: PUBCHEM.COMPOUND:53477739

subject_name: Vasopressin

object_name: myoma


subject: PUBCHEM.COMPOUND:11979316


subject: UMLS:C5966161

subject_name: Vasopressin (anatomical)


subject: UMLS:C1260029

object_name: Diabetic foot ulcer


subject: UMLS:C1260029

object_name: Complications of Diabetes Mellitus


subject: PUBCHEM.COMPOUND:46883775

object_name: ankylosing spondylitis


subject: PUBCHEM.COMPOUND:21873174

subject_name: Testosterone undecanoate

object_name: impotence


subject: PUBCHEM.COMPOUND:21873174

object_name: Erectile Dysfunction, CTCAE


subject: PUBCHEM.COMPOUND:21873174

object_name: Erectile dysfunction


subject: CHEBI:36005

subject_name: docosahexaenoic acid

object_name: amblyopia


subject: CHEBI:28125

subject_name: Doconexent


subject: CHEBI:4975

subject_name: Famotidine

object_name: Drug Interactions


subject: UNII:8G388563M7

subject_name: Telotristat ethyl


subject: CHEBI:176724

subject_name: Etiracetam

object_name: alcohol abuse


subject: CHEBI:176724

object_name: alcohol dependence


subject: CHEBI:176724

object_name: Alcoholic relapse


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: UNII:73HC18Y1LW


subject: UNII:73HC18Y1LW


subject: CHEBI:6437

subject_name: Levetiracetam


subject: CHEBI:6437


subject: CHEBI:6437


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: multiple symmetric lipomatosis


subject: CHEBI:50692

subject_name: Mifepristone

object_name: borderline personality disorder


subject: PUBCHEM.COMPOUND:42602260

subject_name: Capivasertib

object_name: Hormone sensitive prostate cancer


subject: CHEBI:94789

subject_name: Trimetazidine

object_name: coronary artery disorder


subject: CHEBI:94789

object_name: coronary atherosclerosis


subject: CHEBI:94789

object_name: type 2 diabetes mellitus


subject: UMLS:C4733246

subject_name: Gasmotin

object_name: cholecystolithiasis


subject: UMLS:C4733246

object_name: gallstones


subject: UMLS:C4733246

object_name: cholelithiasis


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: Stage IV Renal Cell Cancer


subject: CHEBI:201431

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: CHEBI:201431

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: CHEBI:201431

object_name: untreated childhood acute myeloid leukemia and other myeloid malignancies


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Consent Type - Hysterectomy


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UMLS:C0360094

subject_name: iv lidocaine


subject: UNII:GN429E725A

subject_name: Nedisertib

object_name: Locally Advanced Malignant Solid Neoplasm


subject: UNII:GN429E725A

object_name: Metastatic cholangiocarcinoma


subject: UNII:GN429E725A

object_name: Metastatic Gallbladder Carcinoma


subject: UNII:GN429E725A

object_name: Locally Advanced Unresectable Malignant Solid Neoplasm


subject: UNII:GN429E725A

object_name: Stage III Gallbladder Cancer AJCC v8


subject: UNII:GN429E725A

object_name: Locally Advanced Unresectable Cholangiocarcinoma


subject: UNII:GN429E725A

object_name: Locally Advanced Unresectable Gallbladder Carcinoma


subject: UNII:GN429E725A

object_name: Stage IV Gallbladder Cancer AJCC v8


subject: UMLS:C1384663

object_name: breast neoplasm


subject: UMLS:C1134696


subject: UNII:LDR3USH1NJ

subject_name: Vipadenant

object_name: Parkinson disease


subject: UMLS:C2932006


subject: CHEBI:41423

subject_name: Celecoxib

object_name: ankylosing spondylitis


subject: UMLS:C4045928

object_name: Diabetic Neuralgia


subject: CHEBI:31528

subject_name: Ebastine

object_name: irritable bowel syndrome


subject: CHEBI:146178

subject_name: RACEMETHORPHAN

object_name: relapsing-remitting multiple sclerosis


subject: CHEBI:146176

subject_name: levomethorphan


subject: CHEBI:4470

subject_name: Dextromethorphan


subject: CHEBI:6931

subject_name: Midazolam


subject: CHEBI:7772

subject_name: omeprazole


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:87738

subject_name: (S)-Warfarin


subject: CHEBI:35457

subject_name: EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor

object_name: diabetes mellitus


subject: CHEBI:35457

object_name: type 2 diabetes mellitus


subject: CHEBI:35457

object_name: Insulin resistance


subject: UMLS:C0003015


subject: UMLS:C0003015


subject: UMLS:C0003015


subject: UMLS:C0521942

subject_name: Angiotensin II receptor antagonist


subject: UMLS:C0521942


subject: UMLS:C0521942


subject: UMLS:C0521942

object_name: cardiovascular disorder


subject: UMLS:C0521942

object_name: heart disorder


subject: UMLS:C0815017

subject_name: Angiotensin Receptor Antagonists


subject: UMLS:C0815017


subject: UMLS:C0815017


subject: UMLS:C0815017

object_name: coronary artery disorder


subject: UMLS:C0815017


subject: UMLS:C0815017


subject: UMLS:C0001645

subject_name: Adrenergic beta-Antagonists


subject: UMLS:C0001645


subject: CHEBI:38215

subject_name: calcium channel blocker


subject: CHEBI:38215


subject: CHEBI:38215


subject: CHEBI:38215


subject: CHEBI:38215


subject: CHEBI:38215


subject: UMLS:C0006684

subject_name: Calcium Channel Blockers


subject: UMLS:C0006684


subject: UMLS:C0006684


subject: UMLS:C0006684


subject: UMLS:C0006684


subject: UMLS:C0006684


subject: CHEBI:3095

subject_name: Biguanide


subject: CHEBI:3095


subject: CHEBI:3095


subject: CHEBI:3095


subject: CHEBI:3095


subject: MESH:D001645

subject_name: Biguanides


subject: MESH:D001645


subject: MESH:D001645


subject: MESH:D001645


subject: MESH:D001645


subject: UMLS:C3540012

subject_name: biguanide blood glucose lower drugs


subject: UMLS:C3540012


subject: UMLS:C3540012


subject: UMLS:C3540012


subject: UMLS:C3540012


subject: UMLS:C0360396

subject_name: Biguanide antimalarial


subject: UMLS:C0360396


subject: UMLS:C0360396


subject: UMLS:C0360396


subject: UMLS:C0360396


subject: CHEBI:50990

subject_name: thiazolidinediones


subject: CHEBI:50990


subject: CHEBI:50990


subject: CHEBI:50990


subject: CHEBI:50990


subject: UMLS:C3541957

subject_name: Thiazolidinediones, blood glucose lowering drugs


subject: UMLS:C3541957


subject: UMLS:C3541957


subject: UMLS:C3541957


subject: UMLS:C3541957


subject: UMLS:C3714501

subject_name: Insulin Drug Class


subject: UMLS:C3714501


subject: CHEBI:5931

subject_name: insulin human


subject: CHEBI:5931


subject: PUBCHEM.COMPOUND:140987867

subject_name: Sulfonylurea


subject: PUBCHEM.COMPOUND:140987867


subject: PUBCHEM.COMPOUND:140987867


subject: PUBCHEM.COMPOUND:140987867


subject: CHEBI:76983

subject_name: N-sulfonylurea


subject: CHEBI:76983


subject: CHEBI:76983


subject: CHEBI:76983


subject: CHEBI:26831

subject_name: N,N''-sulfonyldiurea


subject: CHEBI:26831


subject: CHEBI:26831


subject: CHEBI:26831


subject: MESH:D013453

subject_name: Sulfonylurea Compounds


subject: MESH:D013453


subject: MESH:D013453


subject: MESH:D013453


subject: UMLS:C3536898

subject_name: Sulfonylurea [EPC]


subject: UMLS:C3536898


subject: UMLS:C3536898


subject: UMLS:C3536898


subject: CHEBI:136051

subject_name: Lusutrombopag

object_name: Chronic liver disease


subject: UMLS:C2830100

object_name: Primary Insomnia


subject: PUBCHEM.COMPOUND:134517711

subject_name: soquelitinib

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: PUBCHEM.COMPOUND:134517711

object_name: peripheral T-cell lymphoma, not otherwise specified


subject: PUBCHEM.COMPOUND:134517711

object_name: Nodal T-follicular helper cell lymphoma, follicular type


subject: PUBCHEM.COMPOUND:134517711

object_name: Adult Systemic Anaplastic Large Cell Lymphoma


subject: PUBCHEM.COMPOUND:134517711

object_name: Systemic Anaplastic Large Cell Lymphoma


subject: PUBCHEM.COMPOUND:134517711

object_name: anaplastic large cell lymphoma


subject: PUBCHEM.COMPOUND:134517711

object_name: T-Cell Lymphoma


subject: PUBCHEM.COMPOUND:134517711

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: PUBCHEM.COMPOUND:134517711

object_name: angioimmunoblastic T-cell lymphoma


subject: UNII:6I5H17AN3I

subject_name: SOQUELITINIB


subject: UNII:6I5H17AN3I


subject: UNII:6I5H17AN3I


subject: UNII:6I5H17AN3I


subject: UNII:6I5H17AN3I


subject: UNII:6I5H17AN3I


subject: UNII:6I5H17AN3I


subject: UNII:6I5H17AN3I


subject: UNII:6I5H17AN3I


subject: CHEBI:174615

object_name: Ewing sarcoma


subject: CHEBI:28901

subject_name: Busulfan


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:28876

subject_name: Melphalan


subject: UMLS:C0359156

subject_name: Thymoglobulin


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: late complication from kidney transplant


subject: CHEBI:41060

subject_name: IBANDRONATE

object_name: liver cirrhosis


subject: CHEBI:41060

object_name: Hepatic osteodystrophy


subject: UNII:UMD7G2653W

subject_name: Ibandronate


subject: UNII:UMD7G2653W


subject: PUBCHEM.COMPOUND:135449332

subject_name: Eltrombopag

object_name: thrombocytopenia due to immune destruction


subject: PUBCHEM.COMPOUND:135449332

object_name: inherited bleeding disorder, platelet-type


subject: PUBCHEM.COMPOUND:135449332

object_name: blood platelet disease


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Stage IV Lung Cancer AJCC v8


subject: UNII:28X28X9OKV

object_name: Stage IVB Lung Cancer AJCC v8


subject: UNII:28X28X9OKV

object_name: Stage IVA Lung Cancer AJCC v8


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:40279

subject_name: Allopurinol

object_name: Musculoskeletal degeneration


subject: CHEBI:40279

object_name: Inflammation


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: fibrolamellar hepatocellular carcinoma


subject: UNII:DPT0O3T46P

object_name: Childhood Malignant Liver Neoplasm


subject: UNII:DPT0O3T46P

object_name: Adult Liver Carcinoma


subject: CHEBI:6775

subject_name: Mesalazine

object_name: berylliosis


subject: CHEBI:231693

subject_name: Capmatinib

object_name: Childhood Soft Tissue Sarcoma


subject: CHEBI:231693

object_name: Adult Soft Tissue Sarcoma


subject: CHEBI:231693

object_name: sarcoma


subject: CHEBI:231693

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: CHEBI:231693

object_name: soft tissue sarcoma


subject: CHEBI:78432

subject_name: Ceritinib


subject: CHEBI:78432


subject: CHEBI:78432


subject: CHEBI:78432


subject: CHEBI:78432


subject: PUBCHEM.COMPOUND:77256380

subject_name: Glasdegib


subject: PUBCHEM.COMPOUND:77256380


subject: PUBCHEM.COMPOUND:77256380


subject: PUBCHEM.COMPOUND:77256380


subject: PUBCHEM.COMPOUND:77256380


subject: CHEBI:49603

subject_name: Lapatinib


subject: CHEBI:49603


subject: CHEBI:49603


subject: CHEBI:49603


subject: CHEBI:49603


subject: CHEBI:52172

subject_name: Nilotinib


subject: CHEBI:52172


subject: CHEBI:52172


subject: CHEBI:52172


subject: CHEBI:52172


subject: UNII:28X28X9OKV


subject: UNII:28X28X9OKV


subject: UNII:28X28X9OKV


subject: UNII:28X28X9OKV


subject: UNII:28X28X9OKV


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: CHEBI:85993

subject_name: Palbociclib


subject: CHEBI:85993


subject: CHEBI:85993


subject: CHEBI:85993


subject: UMLS:C3827073


subject: UMLS:C3827073


subject: UMLS:C3827073


subject: UMLS:C3827073


subject: UMLS:C3827073


subject: CHEBI:75998

subject_name: Trametinib


subject: CHEBI:75998


subject: CHEBI:75998


subject: CHEBI:75998


subject: CHEBI:75998


subject: CHEBI:75045

subject_name: Dabrafenib


subject: CHEBI:75045


subject: CHEBI:75045


subject: CHEBI:75045


subject: CHEBI:75045


subject: CHEBI:91327

subject_name: Tivozanib

object_name: glioblastoma


subject: CHEBI:91327

object_name: Childhood Glioblastoma


subject: CHEBI:91327

object_name: adult glioblastoma


subject: CHEBI:231614

subject_name: Nivolumab

object_name: smoldering plasma cell myeloma


subject: UMLS:C2346820


subject: PUBCHEM.COMPOUND:42602260

subject_name: Capivasertib

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:42602260

object_name: prostate cancer


subject: UNII:TWF0ML1CK8

subject_name: Fluzoparib

object_name: nasopharyngeal carcinoma


subject: UNII:TWF0ML1CK8

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: UNII:TWF0ML1CK8

object_name: malignant tumor of nasopharynx


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Safety Issues


subject: CHEBI:48045

subject_name: Marizomib

object_name: Plasma cell myeloma refractory


subject: CHEBI:48045

object_name: Relapse multiple myeloma


subject: CHEBI:48045

object_name: Plasma cell myeloma recurrent


subject: UMLS:C0728976

subject_name: Control brand of phenylpropanolamine

object_name: primary peritoneal carcinoma


subject: UMLS:C0728976

object_name: Primary Peritoneal Cancer


subject: UMLS:C0728976

object_name: fallopian tube cancer


subject: UMLS:C0308718

subject_name: CONTROL veterinary product


subject: UMLS:C0308718


subject: UMLS:C0308718


subject: UMLS:C1550141

subject_name: control substance


subject: UMLS:C1550141


subject: UMLS:C1550141


subject: PUBCHEM.COMPOUND:5326857

subject_name: ZA


subject: PUBCHEM.COMPOUND:5326857


subject: PUBCHEM.COMPOUND:5326857


subject: CHEBI:63577

subject_name: Lamivudine

object_name: mild neurocognitive disorder


subject: CHEBI:63577

object_name: mild cognitive impairment


subject: CHEBI:6367

subject_name: Lamotrigine

object_name: Allergy to lamotrigine


subject: CHEBI:76128

subject_name: Dexketoprofen

object_name: Bone fracture


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: Bile acid diarrhea


subject: CHEBI:39548

object_name: Bile acid malabsorption


subject: UMLS:C0073384

subject_name: Ringer's acetate

object_name: Postoperative Complications


subject: UMLS:C0073384

object_name: Fluid Overload


subject: UMLS:C0073384

object_name: Hypervolemia


subject: UMLS:C0073384

object_name: pancreas disorder


subject: CHEBI:34373

subject_name: Gaboxadol

object_name: fragile X syndrome


subject: CHEBI:9352

subject_name: Sulindac


subject: UMLS:C5690696

subject_name: MitoQ

object_name: chronic kidney disease


subject: UMLS:C5690696

object_name: Chronic Kidney Disease, CTCAE


subject: GTOPDB:4942

subject_name: GM-CSF

object_name: rectal carcinoma


subject: GTOPDB:4942

object_name: rectal cancer


subject: GTOPDB:4942

object_name: Childhood Rectal Carcinoma


subject: GTOPDB:4942

object_name: colon carcinoma


subject: GTOPDB:4942

object_name: colon cancer


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: UMLS:C0376563

subject_name: Recombinant Granulocyte-Macrophage Colony-Stimulating Factors


subject: UMLS:C0376563


subject: UMLS:C0376563


subject: UMLS:C0376563


subject: UMLS:C0376563


subject: CHEBI:38940

subject_name: Sunitinib

object_name: metastatic malignant neoplasm in the brain


subject: CHEBI:70746

subject_name: Dabigatran etexilate

object_name: arteriosclerosis disorder


subject: CHEBI:70746

object_name: atherosclerosis


subject: CHEBI:70752

subject_name: Dabigatran


subject: CHEBI:70752


subject: CHEBI:49200

subject_name: EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor

object_name: acute kidney failure


subject: CHEBI:49200

object_name: Acute Kidney Injury, CTCAE


subject: UMLS:C0358591

subject_name: Proton Pump Inhibitors


subject: UMLS:C0358591


subject: UMLS:C3536754

subject_name: Proton Pump Inhibitor [EPC]


subject: UMLS:C3536754


subject: PUBCHEM.COMPOUND:135565609

subject_name: Hetrombopag olamine

object_name: Severe Aplastic Anemia


subject: PUBCHEM.COMPOUND:135565609

object_name: severe aplastic anemia


subject: UMLS:C5418132

subject_name: Hetrombopag Olamine


subject: UMLS:C5418132


subject: CHEBI:95129

subject_name: cisapride

object_name: Heartburn


subject: CHEBI:84094

subject_name: testosterone sulfate

object_name: Advanced cancer


subject: UMLS:C4721537

subject_name: Therapeutic Testosterone


subject: CHEBI:17347

subject_name: Testosterone


subject: UMLS:C3896906

object_name: EGFR T790M Mutation Positive Non-Small Cell Lung Carcinoma


subject: CHEBI:90943

subject_name: Osimertinib


subject: UNII:CMJ4GT6MRD

object_name: amyotrophic lateral sclerosis


subject: CHEBI:232799

subject_name: insulin lispro

object_name: Type 2 diabetes treated with insulin


subject: CHEBI:74705

subject_name: Met-Leu

object_name: alopecia areata


subject: CHEBI:74705

object_name: alopecia


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: UMLS:C0721231


subject: UMLS:C0721231


subject: UNII:N5UK68MGDZ

subject_name: Apremilast

object_name: cardiovascular disorder


subject: UMLS:C0003364

subject_name: Antihypertensive Agents

object_name: hypertension, pregnancy-induced


subject: UMLS:C0003364

object_name: Maternal hypertension


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: Hailey-Hailey disease


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: UMLS:C5828752

object_name: preeclampsia


subject: PUBCHEM.COMPOUND:134506

subject_name: Dehydroandrosterone

object_name: Chronic low back pain


subject: CHEBI:85252

subject_name: synaptamide


subject: CHEBI:89608

subject_name: Cervonoyl ethanolamide


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:16581

subject_name: Pregnenolone


subject: PR:000001256

subject_name: C-X-C chemokine receptor type 1

object_name: Stage IIIC Lung Cancer AJCC v8


subject: PR:000001256

object_name: Stage IV Lung Cancer AJCC v8


subject: PR:000001256

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: PR:000001256

object_name: Non-small cell lung cancer recurrent


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UMLS:C0059079

subject_name: EMLA

object_name: plantar wart


subject: CHEBI:6801

subject_name: Metformin

object_name: Resectable Pancreatic Ductal Adenocarcinoma


subject: CHEBI:231350

subject_name: Pacritinib

object_name: Waldenstrom macroglobulinemia


subject: CHEBI:231350

object_name: B-Cell Lymphoproliferative Disorder


subject: CHEBI:231350

object_name: lymphoplasmacytic lymphoma


subject: UNII:0285I2MVUA

object_name: cocaine dependence


subject: UNII:5TD9324Z2U


subject: UMLS:C3489689


subject: CHEBI:84040

object_name: hereditary spastic paraplegia


subject: CHEBI:36002

subject_name: cis-resveratrol


subject: CHEBI:27881

subject_name: resveratrol


subject: CHEBI:8382

subject_name: Prednisone

object_name: sinusitis


subject: CHEBI:8382

object_name: Sinusitis, CTCAE


subject: MESH:D008081

subject_name: Liposomes

object_name: interstitial cystitis


subject: MESH:D008081

object_name: pelvic pain on the left


subject: MESH:D008081

object_name: pelvic pain occurs with urination


subject: MESH:D008081

object_name: pelvic pain occurs with bowel movement


subject: MESH:D008081

object_name: pelvic pain decreasing in severity


subject: MESH:D008081

object_name: Pelvic pain female


subject: MESH:D008081

object_name: pelvic pain increasing in severity


subject: MESH:D008081

object_name: male pelvic pain


subject: MESH:D008081

object_name: pelvic pain to the rear


subject: MESH:D008081

object_name: pelvic pain on the right


subject: MESH:D008081

object_name: pelvic pain decreasing in frequency


subject: MESH:D008081

object_name: Pelvic pain


subject: MESH:D008081

object_name: Pelvic Pain, CTCAE 5.0


subject: MESH:D008081

object_name: pelvic pain causes awakening at night


subject: MESH:D008081

object_name: pelvic pain increasing in frequency


subject: MESH:D008081

object_name: pelvic pain occurs with intercourse


subject: MESH:D008081

object_name: pelvic pain in front


subject: PUBCHEM.COMPOUND:122527270

subject_name: bemnifosbuvir


subject: UNII:7UM3SQL968


subject: DRUGBANK:DB19050

subject_name: Bemnifosbuvir


subject: CHEBI:8884

subject_name: Rocuronium

object_name: primary interstitial lung disease specific to childhood


subject: CHEBI:8884

object_name: interstitial lung disease specific to childhood


subject: CHEBI:7035

subject_name: Muscimol

object_name: epilepsy


subject: CHEBI:95043

object_name: non-small cell lung carcinoma


subject: CHEBI:95043

object_name: lung cancer


subject: CHEBI:95043

object_name: lung neoplasm


subject: CHEBI:95043

object_name: lung carcinoma


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Recurrent Uterine Corpus Sarcoma


subject: UNII:2S9ZZM9Q9V

object_name: leiomyosarcoma of the corpus uteri


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIIC Uterine Sarcoma AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: sarcoma of uterus stage IIIb


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIIB Uterine Sarcoma AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIIA Uterine Sarcoma AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IVA Uterine Sarcoma AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IVB Uterine Sarcoma AJCC v7


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: UNII:3A58010674

subject_name: Pegfilgrastim


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UMLS:C1550678

subject_name: Water Specimen

object_name: Ileostomy - stoma


subject: UMLS:C1550678

object_name: Intestinal Failure


subject: CHEBI:15377

subject_name: Water


subject: CHEBI:15377


subject: UNII:2946IE3VYD

object_name: relapsed/refractory diffuse large B-cell lymphoma


subject: UNII:2946IE3VYD

object_name: diffuse large B-cell lymphoma


subject: UNII:2946IE3VYD

object_name: Diffuse large B-cell lymphoma recurrent


subject: UNII:2946IE3VYD

object_name: Refractory High Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements


subject: UNII:2946IE3VYD

object_name: Primary mediastinal large B-cell lymphoma refractory


subject: UNII:2946IE3VYD

object_name: Primary mediastinal large B-cell lymphoma recurrent


subject: MESH:D016827

subject_name: CD8 Antigens


subject: MESH:D016827


subject: MESH:D016827


subject: MESH:D016827


subject: MESH:D016827


subject: MESH:D016827


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: UNII:28X28X9OKV

subject_name: Durvalumab


subject: UNII:28X28X9OKV


subject: UNII:28X28X9OKV


subject: UNII:28X28X9OKV


subject: UNII:28X28X9OKV


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:6413

subject_name: Letrozole

object_name: breast adenocarcinoma


subject: PUBCHEM.COMPOUND:46874763

object_name: diverticulitis


subject: UMLS:C0003232

subject_name: Antibiotics


subject: UMLS:C3252350

object_name: Solid Neoplasm


subject: UMLS:C5814312

subject_name: PEG-Glucocerebrosidase

object_name: Gaucher disease


subject: UNII:YUN2306954

subject_name: Cilofexor

object_name: Compensated cirrhosis


subject: UNII:YUN2306954

object_name: sclerosing cholangitis


subject: UNII:YUN2306954

object_name: primary sclerosing cholangitis


subject: PUBCHEM.COMPOUND:22451303

subject_name: Regadenoson

object_name: sickle cell disease


subject: UMLS:C2343930

subject_name: Lexiscan


subject: PUBCHEM.COMPOUND:11422859

object_name: Adult Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:11422859

object_name: childhood myelodysplastic syndrome


subject: PUBCHEM.COMPOUND:11422859

object_name: Myelodysplastic Syndrome, CTCAE


subject: UMLS:C5447482

subject_name: Ligufalimab

object_name: head and neck squamous cell carcinoma


subject: UMLS:C4055105

subject_name: EGFR Antibody


subject: MESH:C000597235

object_name: Advanced Colorectal Carcinoma


subject: UMLS:C1831824

object_name: laryngeal carcinoma


subject: UMLS:C1831824

object_name: larynx cancer


subject: CHEBI:167574

subject_name: Semaglutide

object_name: Disordered Eating Behavior


subject: CHEBI:31355

subject_name: Carboplatin

object_name: extranodal nasal NK/T cell lymphoma


subject: GTOPDB:9592

subject_name: tislelizumab


subject: GTOPDB:9592

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: GTOPDB:9592

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: cognitive disorder


subject: PUBCHEM.COMPOUND:54675783

object_name: psychosis


subject: PUBCHEM.COMPOUND:54675783

object_name: mental disorder


subject: PUBCHEM.COMPOUND:54675783

object_name: psychiatric disorder


subject: PUBCHEM.COMPOUND:54675783

object_name: alcohol-related disorders


subject: PUBCHEM.COMPOUND:54675783

object_name: substance-related disorder


subject: PUBCHEM.COMPOUND:54675783

object_name: Chemically-Induced Disorders


subject: PUBCHEM.COMPOUND:54675783

object_name: Pathologic Processes


subject: PUBCHEM.COMPOUND:54675783

object_name: disease


subject: PUBCHEM.COMPOUND:20802597

subject_name: Sapacitabine

object_name: childhood leukemia


subject: PUBCHEM.COMPOUND:130306983

subject_name: SAFUSIDENIB

object_name: glioma


subject: PUBCHEM.COMPOUND:130306983

object_name: malignant glioma


subject: PUBCHEM.COMPOUND:130306983

object_name: astrocytoma, IDH-mutant, grade 3


subject: PUBCHEM.COMPOUND:130306983

object_name: astrocytoma, IDH-mutant, grade 4


subject: PUBCHEM.COMPOUND:130306983

object_name: glioblastoma


subject: UNII:RCK8KK7SB9


subject: UNII:RCK8KK7SB9


subject: UNII:RCK8KK7SB9


subject: UNII:RCK8KK7SB9


subject: UNII:RCK8KK7SB9


subject: CHEBI:6770

subject_name: MEROPENEM

object_name: urinary tract infection


subject: CHEBI:6770

object_name: Recurrent urinary tract infections


subject: UMLS:C1314417

subject_name: INJECTION, MEROPENEM, 100 MG ADMINISTERED


subject: UMLS:C1314417


subject: CHEBI:43968

subject_name: Meropenem


subject: CHEBI:43968


subject: CHEBI:4672

subject_name: Docetaxel

object_name: malignant neoplasm of esophagus TNM staging primary tumor (T) T4


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:31348

subject_name: Capecitabine

object_name: intrahepatic cholangiocarcinoma


subject: CHEBI:8499

subject_name: Propranolol

object_name: Cirrhosis


subject: UNII:3S252O2Z4X

subject_name: Emapalumab

object_name: Graft failure


subject: UMLS:C4740903

subject_name: emapalumab-lzsg


subject: CHEBI:50733

subject_name: nutraceutical

object_name: skin disorder


subject: CHEBI:7986

subject_name: Pentoxifylline

object_name: fibrosis


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:6129

subject_name: Ketorolac

object_name: proliferative diabetic retinopathy


subject: CHEBI:6129

object_name: Macular Edema


subject: UNII:975UQE9GY6

subject_name: NAVENIBART

object_name: hereditary angioedema


subject: UMLS:C5909030

subject_name: Navenibart


subject: CHEBI:47657

subject_name: Roflumilast

object_name: endogenous depression


subject: CHEBI:47657

object_name: major depressive disorder


subject: CHEBI:91402

subject_name: linsitinib

object_name: Plexosarcoma


subject: CHEBI:91402

object_name: Carney complex


subject: CHEBI:91402

object_name: bone chondrosarcoma


subject: CHEBI:91402

object_name: chondrosarcoma


subject: CHEBI:91402

object_name: paraganglioma


subject: UNII:15A52GPT8T

subject_name: Linsitinib


subject: UNII:15A52GPT8T


subject: UNII:15A52GPT8T


subject: UNII:15A52GPT8T


subject: UNII:15A52GPT8T


subject: CHEBI:231683

subject_name: Anakinra

object_name: intracerebral hemorrhage


subject: UNII:9013DUQ28K


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: Demyelinating sensorimotor neuropathy


subject: UMLS:C4548896

object_name: kidney failure


subject: CHEBI:31355

subject_name: Carboplatin

object_name: renal carcinoma


subject: CHEBI:31355

object_name: kidney neoplasm


subject: CHEBI:31355

object_name: kidney cancer


subject: CHEBI:70839

subject_name: Dasatinib

object_name: childhood germ cell tumor


subject: CHEBI:70839

object_name: testicular germ cell tumor 1


subject: CHEBI:70839

object_name: testicular germ cell tumor


subject: CHEBI:70839

object_name: childhood testicular germ cell tumor


subject: CHEBI:70839

object_name: extragonadal germ cell tumor


subject: CHEBI:70839

object_name: unspecified childhood solid tumor, protocol specific


subject: CHEBI:70839

object_name: Childhood Neuroblastoma


subject: CHEBI:70839

object_name: neuroblastoma


subject: CHEBI:70839


subject: CHEBI:70839


subject: CHEBI:70839


subject: CHEBI:70839

object_name: liver cancer


subject: CHEBI:70839

object_name: liver neoplasm


subject: CHEBI:70839

object_name: Adult Liver Carcinoma


subject: CHEBI:70839

object_name: liver carcinoma


subject: CHEBI:70839

object_name: malignant soft tissue neoplasm


subject: CHEBI:70839

object_name: sarcoma


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514

object_name: renal carcinoma


subject: CHEBI:190514

object_name: kidney neoplasm


subject: CHEBI:190514

object_name: kidney cancer


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375

object_name: childhood germ cell tumor


subject: CHEBI:49375

object_name: testicular germ cell tumor 1


subject: CHEBI:49375

object_name: testicular germ cell tumor


subject: CHEBI:49375

object_name: childhood testicular germ cell tumor


subject: CHEBI:49375

object_name: extragonadal germ cell tumor


subject: CHEBI:49375

object_name: unspecified childhood solid tumor, protocol specific


subject: CHEBI:49375

object_name: Childhood Neuroblastoma


subject: CHEBI:49375

object_name: neuroblastoma


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375

object_name: liver cancer


subject: CHEBI:49375

object_name: liver neoplasm


subject: CHEBI:49375

object_name: Adult Liver Carcinoma


subject: CHEBI:49375

object_name: liver carcinoma


subject: CHEBI:49375

object_name: malignant soft tissue neoplasm


subject: CHEBI:49375

object_name: sarcoma


subject: PUBCHEM.COMPOUND:16760419

subject_name: Etoposide phosphate


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419

object_name: ovarian cancer


subject: PUBCHEM.COMPOUND:16760419

object_name: ovarian neoplasm


subject: PUBCHEM.COMPOUND:16760419

object_name: ovarian carcinoma